Clinical Trial Update: Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating paclitaxel or S-1 in combination with cisplatin-based chemoradiotherapy for esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Mianyang Central Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN